Spectrum Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
SPPI Nasdaq 8731 https://www.sppirx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Spectrum Pharmaceuticals Inc

Spectrum Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement - May 17th, 2023 11:00 am
News Flash: Analysts Just Made A Captivating Upgrade To Their Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Forecasts - May 14th, 2023 12:04 pm
Q1 2023 Assertio Holdings Inc Earnings Call - May 10th, 2023 5:34 am
Spectrum Pharmaceuticals (SPPI) Reports Q1 Loss, Tops Revenue Estimates - May 9th, 2023 12:25 pm
Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update - May 9th, 2023 11:00 am
7 A-Rated Stocks to Buy for May 2023 - May 4th, 2023 10:10 am
Assertio Scoops Up Spectrum Pharma In $248M Stock Deal - Apr 25th, 2023 5:03 pm
Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR Transaction - Apr 25th, 2023 10:00 am
Earnings Update: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Just Reported And Analysts Are Trimming Their Forecasts - Mar 25th, 2023 2:13 pm
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Q4 2022 Earnings Call Transcript - Mar 24th, 2023 11:36 am
Q4 2022 Spectrum Pharmaceuticals Inc Earnings Call - Mar 23rd, 2023 1:50 am
Spectrum Pharmaceuticals (SPPI) Reports Q4 Loss, Tops Revenue Estimates - Mar 22nd, 2023 1:15 pm
Spectrum Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Corporate Update - Mar 22nd, 2023 12:00 pm
Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update - Mar 17th, 2023 11:00 am
Spectrum Pharmaceuticals Receives Permanent J-Code for ROLVEDON™ (eflapegrastim-xnst) Injection (J1449) from U.S. Centers for Medicare & Medicaid Services - Feb 8th, 2023 12:00 pm
Spectrum Pharmaceuticals Provides Update on ROLVEDON™ (eflapegrastim-xnst) Injection and Announces Unaudited Fourth Quarter 2022 Financial Results - Jan 31st, 2023 12:00 pm
The 3 Best Biotech Stocks Under $1 to Buy for January - Jan 26th, 2023 11:06 pm
Spectrum Pharmaceuticals Announces New Employment Inducement Grant for Commercial Staff - Jan 26th, 2023 12:00 pm
Spectrum Pharmaceuticals Announces Management Changes - Jan 4th, 2023 12:00 pm
Spectrum Pharmaceuticals Announces New Employment Inducement Grants for Commercial Staff - Dec 27th, 2022 12:00 pm